Sandro Nuciforo

1.9k total citations · 2 hit papers
17 papers, 1.0k citations indexed

About

Sandro Nuciforo is a scholar working on Molecular Biology, Hepatology and Cancer Research. According to data from OpenAlex, Sandro Nuciforo has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Hepatology and 5 papers in Cancer Research. Recurrent topics in Sandro Nuciforo's work include Cancer, Hypoxia, and Metabolism (3 papers), Liver physiology and pathology (3 papers) and Cancer Cells and Metastasis (3 papers). Sandro Nuciforo is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Liver physiology and pathology (3 papers) and Cancer Cells and Metastasis (3 papers). Sandro Nuciforo collaborates with scholars based in Switzerland, Italy and Germany. Sandro Nuciforo's co-authors include Markus H. Heim, Salvatore Piscuoglio, Luigi Terracciano, Stefan Wieland, Charlotte K.Y. Ng, Matthias S. Matter, Isabel Fofana, Diego Calabrese, Tujana Boldanova and Tanja Blumer and has published in prestigious journals such as Cell, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Sandro Nuciforo

17 papers receiving 1.0k citations

Hit Papers

Organoid Models of Human Liver Cancers Derived from Tumor... 2018 2026 2020 2023 2018 2023 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies
    2018 339 citations Sandro Nuciforo, Isabel Fofana et al. Cell Reports profile →
  2. Arginine reprograms metabolism in liver cancer via RBM39
    2023 145 citations Dirk Mossmann, Christoph Müller et al. Cell profile →

Peers

Sandro Nuciforo
Amanda M. Clark United States
Jin Cen China
Christine Duris United States
Wenwei Zhu China
Zhengfeng Yin China
Rakesh R. Ramjiawan United States
Junbin Liao China
Liangrong Shi China
Jiaming Lai China
Tianhong Su China
Amanda M. Clark United States
Sandro Nuciforo
Citations per year, relative to Sandro Nuciforo Sandro Nuciforo (= 1×) peers Amanda M. Clark

Countries citing papers authored by Sandro Nuciforo

Since Specialization
Citations

This map shows the geographic impact of Sandro Nuciforo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandro Nuciforo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandro Nuciforo more than expected).

Fields of papers citing papers by Sandro Nuciforo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandro Nuciforo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandro Nuciforo. The network helps show where Sandro Nuciforo may publish in the future.

Co-authorship network of co-authors of Sandro Nuciforo

This figure shows the co-authorship network connecting the top 25 collaborators of Sandro Nuciforo. A scholar is included among the top collaborators of Sandro Nuciforo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandro Nuciforo. Sandro Nuciforo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhang, Xiaonan, Lei Zhong, Verónica Rendo, et al.. (2024). Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib. EBioMedicine. 109. 105368–105368. 5 indexed citations
2.
Nuciforo, Sandro, et al.. (2024). Inhibition of the transmembrane transporter ABCB1 overcomes resistance to doxorubicin in patient-derived organoid models of HCC. Hepatology Communications. 8(5). 4 indexed citations
3.
Mossmann, Dirk, Christoph Müller, Sujin Park, et al.. (2023). Arginine reprograms metabolism in liver cancer via RBM39. Cell. 186(23). 5068–5083.e23. 145 indexed citations breakdown →
4.
Tschan, Viviane J., Sandro Nuciforo, Mairene Coto‐Llerena, et al.. (2023). Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer. npj Precision Oncology. 7(1). 112–112. 15 indexed citations
5.
Ng, Charlotte K.Y., Eva Dazert, Mairene Coto‐Llerena, et al.. (2022). Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages. Nature Communications. 13(1). 2436–2436. 88 indexed citations
6.
Kaya, Berna, Sandro Nuciforo, Franz Oswald, et al.. (2022). IL-20 subfamily cytokines impair the oesophageal epithelial barrier by diminishing filaggrin in eosinophilic oesophagitis. Gut. 72(5). 821–833. 25 indexed citations
7.
Meier, Marie‐Anne, Sandro Nuciforo, Mairene Coto‐Llerena, et al.. (2022). Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report. SHILAP Revista de lepidopterología. 2(1). 80–80. 17 indexed citations
8.
Chen, Qian, Mairene Coto‐Llerena, Aleksei Suslov, et al.. (2021). Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses. Nature Communications. 12(1). 4882–4882. 13 indexed citations
9.
Gallon, John, Mairene Coto‐Llerena, Caner Ercan, et al.. (2021). Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma. Molecular Oncology. 16(3). 665–682. 7 indexed citations
10.
Sorrentino, Giovanni, Saba Rezakhani, Ece Yıldız, et al.. (2020). Mechano-modulatory synthetic niches for liver organoid derivation. Nature Communications. 11(1). 3416–3416. 162 indexed citations
11.
Nuciforo, Sandro & Markus H. Heim. (2020). Organoids to model liver disease. JHEP Reports. 3(1). 100198–100198. 111 indexed citations
12.
Calabrese, Diego, Guglielmo Roma, Sebastian Bergling, et al.. (2019). Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells. PLoS ONE. 14(8). e0221762–e0221762. 12 indexed citations
13.
Blumer, Tanja, Isabel Fofana, Matthias S. Matter, et al.. (2019). Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors. Hepatology Communications. 3(7). 971–986. 27 indexed citations
14.
Laux, Holger, Sandro Nuciforo, Christopher J. Farady, et al.. (2018). Degradation of recombinant proteins by Chinese hamster ovary host cell proteases is prevented by matriptase‐1 knockout. Biotechnology and Bioengineering. 115(10). 2530–2540. 33 indexed citations
15.
Nuciforo, Sandro, Isabel Fofana, Matthias S. Matter, et al.. (2018). Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies. Cell Reports. 24(5). 1363–1376. 339 indexed citations breakdown →
16.
Ritter, Anett, Sandro Nuciforo, Bernd Voedisch, et al.. (2016). Fam60A plays a role for production stabilities of recombinant CHO cell lines. Biotechnology and Bioengineering. 114(3). 701–704. 15 indexed citations
17.
Vaillant, Catherine, Paola Valdivieso, Sandro Nuciforo, et al.. (2015). Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma. PLoS ONE. 10(4). e0124870–e0124870. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amanda M. Clark Breakdown of academic impact, for papers by Jin Cen Breakdown of academic impact, for papers by Christine Duris Breakdown of academic impact, for papers by Wenwei Zhu Breakdown of academic impact, for papers by Zhengfeng Yin Breakdown of academic impact, for papers by Rakesh R. Ramjiawan Breakdown of academic impact, for papers by Junbin Liao Breakdown of academic impact, for papers by Liangrong Shi Breakdown of academic impact, for papers by Jiaming Lai Breakdown of academic impact, for papers by Tianhong Su
Rankless by CCL
2026